Trial Profile
A phase I study of ZD6474 (Zactima) and metronomic chemotherapy in advanced breast cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Vandetanib (Primary) ; Cyclophosphamide; Methotrexate
- Indications Advanced breast cancer
- Focus Adverse reactions
- 15 Jun 2012 Planned End Date changed from 1 Jul 2009 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 01 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2009 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.